PRKDC and melanoma: To better understand the transcriptional changes induced by DNA-PK inhibition in melanoma, we conducted RNA-Seq in B16-F10 melanoma cells treated with a vehicle control (DSMO) or NU7441 to explore changes to the antigen landscape, as described previously (38).